Stock MOREPENLAB MOREPEN LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Morepen Laboratories Limited NSE India S.E.

Equities

MOREPENLAB

INE083A01026

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 07:43:49 2024-05-02 am EDT 		5-day change 1st Jan Change
50.3 INR +0.50% Intraday chart for Morepen Laboratories Limited -2.90% +3.60%
Mar. 30 Morepen Laboratories Limited Announces Resignation of Lalit Kumar Baregama, Chief Growth Officer CI
Mar. 01 Morepen Laboratories Limited Announces the Promotion of Amita Sharma to Chief Operating Officer -API CI

Business Summary

Morepen Laboratories Limited is a pharmaceutical company. The Company is in the business of manufacturing, producing, developing and marketing a range of active pharmaceutical ingredients (APIs), branded and generic formulations and also home health products. Its APIs include Apixaban, Edoxaban, Linagliptin, Linagliptin + Metformin, Empagliflozin, Empagliflozin + Metformin, Atorvastatin, Rosuvastain, Rivaroxaban, Febuxostat, Montelukast (Oral), Montelukast (Chewable), among others. Its finished formulations include Intebact Capsules, Intelicaps Lax, Rythmix Kid Drop, Rythmix Kid Syrup, Kompact Powder, Saltum and Acifix 3X Suspension among others. Its home health products include Dr. Morepen 49W Room Air Purifier with HEPA Filter, Dr. Morepen VP06 Breathe Free Vaporizer, Dr. Morepen CN06 Compressor Nebulizer and Dr. Morepen ST03 Dual Head Stethoscope, among others. Its subsidiaries include Dr. Morepen Limited, Morepen Devices Limited, and Total Care Limited.

Number of employees: 1,649

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceuticals
99.7 %
15,416 99.7 % 14,140 99.7 % -8.28%
Export Incentives
0.2 %
29 0.2 % 31 0.2 % +8.65%
Others
0.0 %
24 0.2 % 4 0.0 % -81.71%

Sales per region

INR in Million2022Weight2023Weight Delta
India
60.1 %
9,827 63.7 % 8,499 60.1 % -13.51%
Rest of World
33.7 %
4,582 29.7 % 4,761 33.7 % +3.90%
United States
6.2 %
1,007 6.5 % 879 6.2 % -12.63%

Managers

Managers TitleAgeSince
Sushil Suri CEO
 Chief Executive Officer 60 92-01-31
Ajay Kumar Sharma DFI
 Director of Finance/CFO 57 02-04-02
Vipul Kumar Srivastava CMP
 Compliance Officer 38 18-11-11
Madan Pal Tanwar CTO
 Chief Tech/Sci/R&D Officer 59 -
Rajiv Jain AUD
 Comptroller/Controller/Auditor - -
Shantanu Tuli PRN
 Corporate Officer/Principal - -
Sumit Bhatnagar AUD
 Comptroller/Controller/Auditor - -
Mahinder Kumar Sharma LAW
 General Counsel - -

Members of the board

Members of the board TitleAgeSince
Sanjay Suri BRD
 Director/Board Member 55 19-08-12
Sushil Suri CEO
 Chief Executive Officer 60 92-01-31
Sukhcharan Singh BRD
 Director/Board Member 81 05-06-14
Manoj Joshi BRD
 Director/Board Member 67 92-06-26
Bhupender Raj Wadhwa BRD
 Director/Board Member 59 05-06-14
Praveen Kumar Dutt BRD
 Director/Board Member 55 19-08-12
Savitha BRD
 Director/Board Member - 20-06-21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 511,168,708 266,690,049 ( 52.17 %) 0 52.17 %

Shareholders

NameEquities%Valuation
PINFOLD OVERSEAS LTD
7.538 %
38,530,000 7.538 % 19 M ₹
Scope Credits & Financial Services Pvt. Ltd.
3.047 %
15,575,405 3.047 % 8 M ₹
Concept Credits & Consultants Pvt. Ltd.
3.002 %
15,347,724 3.002 % 8 M ₹
Brook Investments & Financial Services Pvt Ltd.
2.966 %
15,159,252 2.966 % 8 M ₹
Solitary Investment & Financial Services Pvt Ltd.
2.957 %
15,114,045 2.957 % 8 M ₹
Solace Investments & Financial Services Pvt Ltd.
2.951 %
15,082,790 2.951 % 8 M ₹
Mid-Med Financial Services & Investments Pvt Ltd.
2.929 %
14,973,813 2.929 % 8 M ₹
React Investments & Financial Services Pvt Ltd.
2.923 %
14,942,134 2.923 % 8 M ₹
Epitome Holdings Pvt. Ltd.
2.837 %
14,500,820 2.837 % 7 M ₹
Seed Securitys & Services Pvt. Ltd.
2.803 %
14,328,780 2.803 % 7 M ₹

Holdings

NameEquities%Valuation
MOREPEN LABORATORIES LIMITED
1.04%
 5,329,253 1.04% 2,687,542 $

Company contact information

Morepen Laboratories Ltd.

Tower C, DLF Cyber Park 2nd Floor, Sector 20

122016, Gurugram

+91 12 4489 2000

http://www.morepen.com
address Morepen Laboratories Limited(MOREPENLAB)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+29.68% 699B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.07% 571B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.35% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.65% 326B
ABBVIE INC. Stock AbbVie Inc.
+3.77% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.68% 236B
NOVARTIS AG Stock Novartis AG
+4.71% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-12.43% 194B
PFIZER, INC. Stock Pfizer, Inc.
-3.79% 154B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. MOREPENLAB Stock
  4. MOREPENLAB Stock
  5. Company Morepen Laboratories Limited